neoSurgical

neoSurgical is a commercial-stage company with FDA approval for neoClose®, designed to be the standard for laparoscopic surgery port site closure.

  • Stage $500K in TTM Revenue
  • Location Atlanta, GA, US
  • Currency USD
  • Incorporation Type LLC

Company Summary

The standard for port site closure has been Closed Loop Suture. neoClose® is a superior alternative that closes the port site with a Vector X Closure that approximates the tissue resulting in 75% less tension. There are no other devices on the market today that approximates tissue to close a port site. All competing products use a closed loop suture, which places a higher level of tension on tissue.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free